Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R Bliss

Safety and Immunogenicity of the rVSV∆G-ZEBOV-GP Ebola Virus Vaccine Candidate in Healthy Adults: A Phase 1b Randomised, Multicentre, Double-Blind, Placebo-Controlled, Dose-Response Study

The Lancet Infectious Diseases

Infectious Diseases

2017

English

Related publications

Safety and Immunogenicity of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine in Healthy Adults in Sierra Leone: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial

The Lancet

Medicine

2017

English

One-Year Safety of the Rvsv∆g-Zebov-Gp Vaccine in Adolescents and Children in Lambarene, Gabon

English

A Phase 2/3 Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Seasonal Trivalent Inactivated Split-Virion Influenza Vaccine (IVACFLU-S) in Healthy Adults in Vietnam

Human Vaccines and Immunotherapeutics

English

Immunity Duration of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine and a Homologous Prime-Boost Immunisation in Healthy Adults in China: Final Report of a Randomised, Double-Blind, Placebo-Controlled, Phase 1 Trial

The Lancet Global Health

Medicine

2017

English

Safety and Immunogenicity of a Parenteral P2-Vp8-P[8] Subunit Rotavirus Vaccine in Toddlers and Infants in South Africa: A Randomised, Double-Blind, Placebo-Controlled Trial

The Lancet Infectious Diseases

Infectious Diseases

2017

English

Diclofenac Patch for Topical Treatment of Acute Impact Injuries: A Randomised, Double Blind, Placebo Controlled, Multicentre Study

British Journal of Sports Medicine

English

Randomised, Double-Blind, Placebo-Controlled Trial of EPs 7630 in Adults With COPD

English

Efficacy and Safety of Analgesic Treatment for Depression in People With Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)

English

A 6-Week, Multicentre, Randomised, Double-Blind, Double-Dummy, Active-Controlled, Clinical Safety Study of Lumiracoxib and Rofecoxib in Osteoarthritis Patients

BMC Musculoskeletal Disorders

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R Bliss

Safety and Immunogenicity of the rVSV∆G-ZEBOV-GP Ebola Virus Vaccine Candidate in Healthy Adults: A Phase 1b Randomised, Multicentre, Double-Blind, Placebo-Controlled, Dose-Response Study

Related publications

Safety and Immunogenicity of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine in Healthy Adults in Sierra Leone: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial

One-Year Safety of the Rvsv∆g-Zebov-Gp Vaccine in Adolescents and Children in Lambarene, Gabon

A Phase 2/3 Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Seasonal Trivalent Inactivated Split-Virion Influenza Vaccine (IVACFLU-S) in Healthy Adults in Vietnam

Immunity Duration of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine and a Homologous Prime-Boost Immunisation in Healthy Adults in China: Final Report of a Randomised, Double-Blind, Placebo-Controlled, Phase 1 Trial

Safety and Immunogenicity of a Parenteral P2-Vp8-P[8] Subunit Rotavirus Vaccine in Toddlers and Infants in South Africa: A Randomised, Double-Blind, Placebo-Controlled Trial

Diclofenac Patch for Topical Treatment of Acute Impact Injuries: A Randomised, Double Blind, Placebo Controlled, Multicentre Study

Randomised, Double-Blind, Placebo-Controlled Trial of EPs 7630 in Adults With COPD

Efficacy and Safety of Analgesic Treatment for Depression in People With Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)

A 6-Week, Multicentre, Randomised, Double-Blind, Double-Dummy, Active-Controlled, Clinical Safety Study of Lumiracoxib and Rofecoxib in Osteoarthritis Patients